Fifth Third Named Among the Best and Brightest in Wellness by National Association for Business Resources
"This award highlights Fifth Third's dedication to fostering a workplace culture that prioritizes wellness through support, education and encouragement – helping employees lead happier, healthier lives," said Nancy Pinckney, chief human resources officer at Fifth Third. "Our innovative wellness programs are designed to help support employees holistically, including improving or sustaining their physical, financial, emotional and social well-being."
Fifth Third continues to invest in the well-being of its employees through a comprehensive suite of benefits. The Bank also offers wellness and employee assistance programs, virtual and maternity concierge services, along with on-site concierges in larger locations, and subsidized back-up care for children and elder adults.
The Nation's Best and Brightest in Wellness winning companies were evaluated by an assessment created and administered by a leading wellness research firm. Each entry was examined statistically for quantitative and qualitative data. Each survey was scored on a point system based upon criteria to benchmark and improve wellness program effectiveness. Best and Brightest in Wellness award winners were evaluated based on various categories, including wellness program culture, environment and employee input; onsite and remote offerings; physical health; mental health; financial health; leadership commitment; and outcomes, evaluation, analysis and tracking.
About Fifth Third
Fifth Third is a bank that's as long on innovation as it is on history. Since 1858, we've been helping individuals, families, businesses and communities grow through smart financial services that improve lives. Our list of firsts is extensive, and it's one that continues to expand as we explore the intersection of tech-driven innovation, dedicated people and focused community impact. Fifth Third is one of the few U.S.-based banks to have been named among Ethisphere's World's Most Ethical Companies® for several years. With a commitment to taking care of our customers, employees, communities and shareholders, our goal is not only to be the nation's highest performing regional bank, but to be the bank people most value and trust.
Fifth Third Bank, National Association is a federally chartered institution. Fifth Third Bancorp is the indirect parent company of Fifth Third Bank and its common stock is traded on the NASDAQ® Global Select Market under the symbol "FITB." Investor information and press releases can be viewed at www.53.com. Deposit and credit products provided by Fifth Third Bank, National Association. Member FDIC.
About the National Association for Business Resources
The Best and Brightest in Wellness, Best and Brightest Companies to Work For, Best and Brightest CEOs and Leadership Teams in the Nation are programs of the National Association for Business Resources, and are presented in several markets: Atlanta, Charlotte, Chicago, Dallas/Fort Worth, Denver, Detroit, Houston, Miami, Milwaukee, Nashville, New England, New York, Northern California, Pacific Northwest, Southern California, West Michigan and Nationally. Nominations are now being accepted for all programs. Visit https://nationalbiz.org/ to obtain an application.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250609762538/en/
Contacts
Derek Cuculich (Media Relations)derek.cuculich@53.com Matt Curoe (Investor Relations)matt.curoe@53.com | 513-534-2345
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
32 minutes ago
- Business Upturn
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
NEW YORK, July 12, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PepGen Inc. (NASDAQ: PEPG) between March 7, 2024 and March 3, 2025, both dates inclusive (the 'Class Period'), of the important August 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased PepGen securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the PepGen class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 8, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) PGN-EDO51 was less effective and safe than defendants had led investors to believe; (2) the CONNECT2 study was dangerous or otherwise deficient for purposes of U.S. Food and Drug Administration ('FDA') approval; (3) as a result of all the foregoing, PepGen was likely to halt the CONNECT2 study, and PGN-ED051's clinical, regulatory, and commercial prospects were overstated; and (4) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the PepGen class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. ——————————- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected]
Yahoo
2 hours ago
- Yahoo
Here's Why Aehr Test Systems Stock Had a Wild Ride in the First Half of 2025
Aehr's traditional end markets are suffering from a slowdown in electric vehicle investment. The company has successfully opened up new markets that could potentially be far larger than its core silicon carbide end market. 10 stocks we like better than Aehr Test Systems › Shares in Aehr Test Systems (NASDAQ: AEHR) slumped by 22.2% in the first half of 2025, according to data provided by S&P Global Market Intelligence. That figure may surprise investors, not least because it's a long, long way from telling the whole story of a stock that declined 56% in the first three months of 2025 only to rise 77.4% in the last three months of the half-year. The fall and rise of the stock mirrors the narrative around it and its end markets. The company recently reported its full-year financial 2025 earnings. For the sake of clarity, its financial year ends on May 30. Going back to focusing on the first six months of the calendar year, Aehr started the year with most investors thinking of it as a company focused on the silicon carbide (SiC) wafer-level burn-in (WLBI) market, and with good reason, because the SiC WLBI market accounted for 90% of its sales in its financial year 2024. ON Semiconductor (NASDAQ: ON) has previously been named as a significant customer, and its sales slowdown has mirrored a broader slowdown in the SiC market, principally in the electric vehicle (EV) market. A combination of an ongoing relatively high interest rate and a correction from a previous boom in EV spending meant Aehr couldn't rely on the SiC WLBI market for growth in its financial 2025. Indeed, CEO Gayn Erickson recently outlined that SiC WLBI "made up less than 40% of our revenue this fiscal '25." As such, the story of Aehr's first three months was disappointing, as its EV end market for SiC WLBI equipment continued to weaken. The significant turnaround in the stock's fortunes in 2025 occurred in the third-quarter earnings report in April, when management announced it was expanding into new markets and was on track to generate 35% of its revenue (later confirmed) from the artificial intelligence (AI) processor burn-in market. In addition, management said it had "four customers representing over 10% of revenue, and three of these are new markets," including WLBI of gallium nitride (GaN) semiconductor supply to the automotive market. Furthermore, on the fourth-quarter earnings release, Erickson said it had secured "a major hyperscaler" as a first production AI customer in the packaged part burn-in (PPBI) market. While Aehr isn't naming these significant customers, a slide deck of its customers includes names like Microsoft, Alphabet's Google, Nvidia, ON Semiconductor, and Infineon, among many others. Management believes its AI end markets are potentially 3 to 5 times larger than its traditional SiC markets, and that optimism is fueling the current stock price strength. Before you buy stock in Aehr Test Systems, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Aehr Test Systems wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,477!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,010,880!* Now, it's worth noting Stock Advisor's total average return is 1,047% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of July 7, 2025 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Lee Samaha has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Microsoft, and Nvidia. The Motley Fool recommends ON Semiconductor and recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. Here's Why Aehr Test Systems Stock Had a Wild Ride in the First Half of 2025 was originally published by The Motley Fool
Yahoo
3 hours ago
- Yahoo
Supermicro (SMCI) Target Raised by Citi as AI Demand Heats Up
July 11 Shares of Super Micro Computer (NASDAQ:SMCI) dipped nearly 1% lower on Friday morning despite multiple analyst actions, including a price target hike from Citi. Warning! GuruFocus has detected 5 Warning Signs with SMCI. Citi lifted its price target on SMCI to $52 from $37 while keeping a Neutral rating. The brokerage cited growing enterprise and sovereign demand for AI-focused infrastructure and noted the company's ongoing efforts to meet its near-term delivery goals. The updated valuation reflects a shift to a 13.5x earnings multiple from the prior 9x to 10x range. The analysts flagged a broader ramp-up in Supermicro's GB200 and GB300 products that began in May. While AI and server market tailwinds persist, Citi warned that intensifying competition from Dell Technologies (NYSE:DELL) and Hewlett Packard Enterprise (NYSE:HPE) could pressure profit margins. Separately, Mizuho also raised its price target to $47 and reiterated a Neutral stance, citing robust cloud and AI server orders. Meanwhile, KeyBanc initiated coverage with a Sector Weight rating, noting the competitive dynamics in the space. Earlier this week, SMCI priced $2 billion in convertible senior notes due 2030, with a $300 million greenshoe option. Proceeds will support general corporate purposes and growth plans. The company also received immersion cooling certification for its BigTwin server from Intel (NASDAQ:INTC). Investors remain cautious ahead of SMCI's earnings report expected in early August. This article first appeared on GuruFocus.
